PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7177252

Decrease in pyrrole-2-carboxylic acid excretion during lung cancer disease.

E Svojtková·Z Deyl·J Andrlíková
View original source ↗Export metadata ↓

Abstract

A statistically significant decrease of pyrrole-2-carboxylic acid in urine was observed in lung cancer of stage I (TNM classification) when compared to that of healthy miners (chronically exposed to radiation) from the uranium industry. The difference vanishes in stage II of the disease and reappears in stage III. While nonmalignant lung diseases (bronchopneumonia and chronic bronchitis) do not interfer in the stage I with the drop of pyrrole-2-carboxylic acid excretion, in stage III of lung cancer the decrease is less pronounced and cannot be differentiated from that found in bronchopneumonia or chronic bronchitis.

Explore related subjects

CollagenHumansHydroxyprolineLung NeoplasmsProlineJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E Svojtková, Z Deyl, J Andrlíková. 1982. Decrease in pyrrole-2-carboxylic acid excretion during lung cancer disease.. https://pubmed.ncbi.nlm.nih.gov/7177252/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1996

Immunolocalization of alpha-integrin subunits and extracellular matrix components during human colonic organogenesis.

BACKGROUND & AIMS: The role of cell adhesion molecules in colonic organogenesis remains poorly understood. This study examined the expression of alpha-integrin subunits and extracellular matrix ligands during human colonic development. METHODS: Standard immunohistochemistry was used to characterize extracellular matrix and alpha-integrin subunit expression during development. RESULTS: At 9 weeks, type-IV collagen and laminin were present underlying epithelium, around vascular structures, and surrounding inner circular muscle layer fibers. Fibronectin was uniformly expressed in the mesenchyme. Tenascin distribution was restricted to the presumptive muscle layer and, later, to the villus core and muscularis mucosae. The 9-week epithelium expressed alpha 2, alpha 3, alpha 5, and alpha 8, and, by 11 weeks, alpha 9. alpha 3, alpha 6, and alpha 8 expression was accentuated at the basal membrane. During transition from pseudostratified to simple columnar epithelium, a vertical alpha 2 gradient formed. Mesenchymal cells expressed alpha 5 and alpha 8 by 9 weeks. The developing muscularis (propria and mucosae) showed accentuated alpha 5 expression. By 16 weeks, alpha 8 expression localized to the muscularis mucosae and villus core. Mesenchymal vascular elements stained strongly with anti-alpha 2 and alpha 6 by 9 weeks. CONCLUSIONS: These observations show the complexity and overlap of adhesive receptor expression and ligands during development and reveal early cell commitment to the formation of specific structures.

Collagen↗
PubMed1996

Transurethral collagen injections in the therapy of post-radical prostatectomy stress incontinence.

PURPOSE: We report on our initial results with glutaraldehyde cross-linked collagen used as an injectable bulking agent for the therapy of post-radical prostatectomy stress incontinence. MATERIALS AND METHODS: A total of 19 men underwent collagen injection for treatment of post-radical prostatectomy stress incontinence. RESULTS: Of the 19 patients treated 11 had either a good (4) or improved (7) result, for an overall satisfaction rate of 58% with a followup of 3 to 15 months (mean 10.4). Failure correlated with presence of bladder neck contracture or scarring and severity of incontinence. CONCLUSIONS: Injection of collagen for stress incontinence after radical prostatectomy has an acceptable short-term success rate, particularly in men with milder incontinence and lack of bladder neck scarring.

Collagen↗